Beta test rollout. This site is in community QA — please send feature requests, bug reports and data corrections on the Feedback page or on GitHub.

Home
    Disclaimer
    2C-TFM molecular structure

    2C-TFM Stats & Data

    2c-cf3
    PubChem
    MW249.23
    FormulaC11H14F3NO2
    LogP2.1
    IUPAC2-[2,5-dimethoxy-4-(trifluoromethyl)phenyl]ethanamine
    InChIKeyLYXGNMLWYONZID-UHFFFAOYSA-N
    Chemical Class 2C-x phenethylamine
    Psychoactive Class Psychedelic

    Effect Profile

    Curated + 14 Reports
    Psychedelic 6.6

    Strong visuals with moderate auditory effects and body load, mild headspace

    Visual Intensity×3
    105.2
    Headspace Depth×3
    44.3
    Auditory Effects×1
    7
    Body Load / Somatic Effects×1
    65.0
    Catalog BlueLight
    Based on reports from:

    Tolerance & Pharmacokinetics

    drugs.wiki

    Tolerance Decay

    Full tolerance 1h Half tolerance 10d Baseline ~14d

    Experience Report Analysis

    Erowid BlueLight
    6 Reports
    4 Single-substance
    2010–2025 Date Range
    6 With Age Data
    5 Effects Detected

    Demographics

    Gender Distribution

    Too few reports for a chart: gender is known from 6 reports, and a split is drawn only from 20 reports or more. Counts are shown instead. Why 20?

    • Male 3 of 6
    • Female 3 of 6

    Age Distribution

    Reports Over Time

    Effect Analysis

    Erowid + Bluelight

    Effects aggregated from 14 experience reports (4 single-substance Erowid + 10 Bluelight)

    14 Reports
    65 Effects Detected
    46 Positive
    8 Adverse
    11 Neutral

    Effect Sentiment Distribution

    Confidence Distribution

    Each bar is the share of reports mentioning the effect; its whisker, and the band on the rows below, is the 95% interval: where the share could plausibly be with other reports of the same kind.

    Too few reports for bars: these effects come from 4 single-substance Erowid and 10 analyzed Bluelight reports, and a bar is drawn only from 20 reports or more. With fewer, a percentage cannot tell a common effect from a rare one. Counts are shown instead. Why 20?

    Positive Effects 46

    Body High 7 of 10 80%
    Stimulation 9 of 14 78%
    Euphoria 6 of 10 88%
    Closed-Eye Visuals 7 of 14 81%
    Color Enhancement 7 of 14 90%
    Visual Trails 4 of 10 81%
    Joy 4 of 10 85%
    Empathy 5 of 14 85%
    Open-Eye Visuals 3 of 10 83%
    Music Enhancement 3 of 10 93%
    Introspection 3 of 10 73%
    Clarity 3 of 10 83%
    Contentment 2 of 10 85%
    Thought Connectivity 2 of 10 75%
    Awe 2 of 10 82%
    Insight 2 of 10 85%
    Focus Enhancement 2 of 10 82%
    Creativity Enhancement 2 of 10 78%
    Emotional Openness 2 of 10 78%
    Sociability Enhancement 2 of 10 82%

    Adverse Effects 8

    Nausea 3 of 10 72%
    Anxiety 2 of 10 72%
    Motor Suppression 2 of 10 70%
    Body Load 2 of 10 80%
    Sweating 1 of 10 85%
    Tremor 1 of 10 75%
    Insomnia 1 of 10 70%
    Stomach Discomfort 1 of 10 65%
    Show 11 neutral or unclassified mentions
    Sedation 4 of 14
    Thought Deceleration 2 of 10
    Pupil Dilation 2 of 10
    Confusion 2 of 10
    Lightheadedness 1 of 10
    Appetite Suppression 1 of 10
    Perspective Distortion 1 of 10
    Jaw Clenching 1 of 10
    Body Temperature Change 1 of 10
    Blurred Vision 1 of 10
    Time Distortion 1 of 10

    Real-World Dose Distribution

    Erowid

    From 5 of 7 recorded dose entries: those that state a weight (mg, g or µg), in routes with at least five of them. Values above Q3 + 3×IQR, far above what people typically take, are left out; they can include real heavy doses and overdoses, not only mistakes.

    Oral (n=5)

    Median: 3.5mg 25th: 3.0mg 75th: 4.8mg 90th: 5.82mg

    Form / Preparation

    Most common forms and preparations, as a share of the 3 reports that give one

    Too few reports for bars: these forms come from 3 reports, and a bar is drawn only from 20 reports or more. With fewer, a percentage cannot tell a common effect from a rare one. Counts are shown instead. Why 20?

    • Powder / Crystals 3 of 3
    ← Back to 2C-TFM